1H6NLREm0M7ksWj8GkMdbq2XYWX3dWoWEc91GVETArM
At OrphAI Therapeutics, we are focused on identifying and developing treatments for conditions with unmet medical need. Our current drug candidates target several orphan disorders including pulmonary hypertension, bronchiolitis obliterans post lung transplant, and SWI/SNF mutated or dysregulated cancer.